NYSE ORDER IMBALANCE 237356.0 SHARES ON BUY SIDE
19/03/2021 19:50
NYSE ORDER IMBALANCE CLB.N 237356.0 SHARES ON BUY SIDE
Recent news on Core Laboratories
See all newsCore Laboratories Q1 profit halves as Middle East disruptions, weather weigh
Brief: Core Laboratories Q1 EPS USD -0.02
Brief: Core Laboratories Expects Q126 Revenue And Earnings Below Prior Guidance
Brief: Core Laboratories Expects Q1 Rev Between $124 Mln To $130 Mln
Oilfield services firm Core Laboratories' Q4 revenue rises